Vanta Bioscience Limited, together with its subsidiaries, operates as a preclinical contract research organization in India. It provides toxicology evaluation services for clientele in pharmaceutical, biotech, medical device, cosmetics, agri-foods, food supplements, feed additives, and chemical industries. The company offers range of services in method development, validation, impurity profiling, impurity isolation, characterization, certification and evaluation, mammalian and genetic toxicology, drug metabolism, pharmacokinetics, and bio-analysis during the preclinical stage of drug development. In addition, it provides testing services for agrochemicals and chemicals, such as physico-chemical testing; sub-acute, sub-chronic, and chronic; toxicokinetics assessment, CoA and dose formulation analysis, 5 batch Analysis, and studies on behavior in water, soil and air, bioaccumulation, as well as acute 6 pack, carcinogenicity, genetic toxicity, DART, eco-toxicity, and alternative to animal studies. Further, the company offers diet formulation services, which include starter material processing, proximate and composition analysis, diet balancing and formulation, irradiation, and packaging and labeling; and batch release pharmacopoeia tests, such as pyrogen testing, stability studies, and abnormal toxicity and impurity profiling. It also engages in the provision of services to medical device industry including cytotoxicity, intracutaneous / mucous membrane irritation, dermal sensitization, mutagenicity assays, acute systemic toxicity, and implantation tests. Vanta Bioscience Limited was incorporated in 2016 and is based in Secunderabad, India.